Evidence map›Paper›PMID 27160415›Full record

ReviewBiotechnology progress2016

Rapid separation of bacteria from blood-review and outlook.

William G Pitt, Mahsa Alizadeh, Ghaleb A Husseini, Daniel S McClellan, Clara M Buchanan, Colin G Bledsoe, Richard A Robison, Rae Blanco, Beverly L Roeder, Madison Melville and 1 more

Open access · greenAbstract readReview
In one paragraph

Review in Biotechnology progress, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Carbapenem-ResistantNanomaterials (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Review
  14. Growth and Distribution of Bacteria in Contaminated Whole Blood and Derived Blood Components.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

William G PittDept. of Chemical Engineering, Brigham Young University, Provo, UT.
Mahsa AlizadehDept. of Chemical Engineering, Brigham Young University, Provo, UT.
Ghaleb A HusseiniDept. of Chemical Engineering, American University of Sharjah, Sharjah, UAE.
Daniel S McClellanDept. of Chemical Engineering, Brigham Young University, Provo, UT.
Clara M BuchananDept. of Chemical Engineering, Brigham Young University, Provo, UT.
Colin G BledsoeDept. of Chemical Engineering, Brigham Young University, Provo, UT.
Richard A RobisonDept. of Microbiology and Molecular Biology, Brigham Young University, Provo, UT.
Rae BlancoDept. of Chemical Engineering, Brigham Young University, Provo, UT.
Beverly L RoederDept. of Biology, Brigham Young University, Provo, UT.
Madison MelvilleDept. of Chemical Engineering, Brigham Young University, Provo, UT.
Alex K HunterDept. of Chemical Engineering, Brigham Young University, Provo, UT.
Brigham Young University · USAmerican University of Sharjah · AE

Funding

Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic PlatformR01AI116989 · NIAID · BRIGHAM YOUNG UNIVERSITY · PI HAWKINS, AARON R., PITT, WILLIAM G · 2015 to 2019
$5.4M
NIAID NIH HHS R01 AI116989
6 · The paper itself

Abstract

The high morbidity and mortality rate of bloodstream infections involving antibiotic-resistant bacteria necessitate a rapid identification of the infectious organism and its resistance profile. Traditional methods based on culturing the blood typically require at least 24 h, and genetic amplification by PCR in the presence of blood components has been problematic. The rapid separation of bacteria from blood would facilitate their genetic identification by PCR or other methods so that the proper antibiotic regimen can quickly be selected for the septic patient. Microfluidic systems that separate bacteria from whole blood have been developed, but these are designed to process only microliter quantities of whole blood or only highly diluted blood. However, symptoms of clinical blood infections can be manifest with bacterial burdens perhaps as low as 10 CFU/mL, and thus milliliter quantities of blood must be processed to collect enough bacteria for reliable genetic analysis. This review considers the advantages and shortcomings of various methods to separate bacteria from blood, with emphasis on techniques that can be done in less than 10 min on milliliter-quantities of whole blood. These techniques include filtration, screening, centrifugation, sedimentation, hydrodynamic focusing, chemical capture on surfaces or beads, field-flow fractionation, and dielectrophoresis. Techniques with the most promise include screening, sedimentation, and magnetic bead capture, as they allow large quantities of blood to be processed quickly. Some microfluidic techniques can be scaled up. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:823-839, 2016.

Indexed as

BacteriaBacterial InfectionsHumansPolymerase Chain Reactionbacterial bloodstream infectioncentrifugationchemical bindingfiltrationhydrodynamic focusingrapid identificationsedimentation

Identifiers

PMID27160415
PMCPMC5297886
OpenAlexW2359690404

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.